Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Patricia J. Zettler"'
Autor:
Seema K. Shah, Patricia J. Zettler
Publikováno v:
American journal of public health. 111(10)
Autor:
Patricia J. Zettler, Laertis Ikonomou, Aaron D. Levine, Leigh Turner, Bambi Grilley, Beth E. Roxland
Publikováno v:
Cytotherapy.
Publikováno v:
SSRN Electronic Journal.
Autor:
Patricia J. Zettler
Publikováno v:
Citizen Science: Theory and Practice; Vol 7, No 1 (2022); 43
Much of the analysis of the public health legal and regulatory mechanisms that potentially apply to biomedical citizen science activities in the United States has focused on the federal government, including US Food & Drug Administration (FDA) and hu
Publikováno v:
New England Journal of Medicine. 385:2409-2411
A Divisive Ruling on Devices The FDA has long taken the legal position that regulated devices could also be categorized as drugs. But according to a recent case, products meeting the definition of ...
Autor:
Patricia J Zettler
Publikováno v:
EMBO Molecular Medicine, Vol 7, Iss 10, Pp 1248-1250 (2015)
Abstract In addition to being an example of unsubstantiated hype about regenerative medicine, the controversy around the Italy‐based Stamina Foundation's unproven stem cell therapy represents another chapter in a continuing debate about how to bala
Externí odkaz:
https://doaj.org/article/36ce2f65ff474c44b64ece7d4ae8e6e2
Autor:
Natividad Cuende, Rachele Ciccocioppo, Miguel Forte, Jacques Galipeau, Laertis Ikonomou, Bruce L. Levine, Alok Srivastava, Patricia J. Zettler
Hospital exemption (HE) is a regulated pathway that allows the use of advanced therapy medicinal products (ATMPs) within the European Union (EU) under restrictive conditions overseen by national medicine agencies. In some EU countries, HE is granted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b4cb551971070be6d3dfdf523134a3
https://hdl.handle.net/10668/22299
https://hdl.handle.net/10668/22299
Publikováno v:
J Clin Oncol
Autor:
Patricia J. Zettler, Ameet Sarpatwari
Publikováno v:
The New England journal of medicine. 386(8)
Autor:
Timothy K. Knilans, Govind Persad, Armand H. Matheny Antommaria, Holly Fernandez Lynch, Patricia J. Zettler, Jennifer E deSante-Bertkau
Publikováno v:
Pediatrics. 149
The US Food and Drug Administration (FDA) approval of the biologics license application for the Pfizer-BioNTech coronavirus disease 2019 vaccine (Comirnaty) on August 23, 2021, opened the door to the off-label vaccination of children younger than the